in Europe the multifactorial clinical approach to the prevention of coronary heart disease is based on the Framingham equation presented in graphical form including age, sex, level of total serum cholesterol, systolic blood pressure and smoking.
Objective
To propose a straightforward paper-and-pencil score (Global Coronary Risk Score) including level of high-density lipoprotein cholesterol for the Belgian or more broadly western European population derived from 10-year follow-up mortality of a Belgian national population sample.
Results
This score has the same predictive power as the Framingham equation both for men aged 35–74 years and for women aged 50–74 years. It gives a ranking of subjects into four groups according to their relative risks.
Conclusion
Coronary Risk Score is user friendly and probably has pedagogical virtues.
TruettJCornfieldJKannelWB.A multivariate analysis of the risk of coronary heart disease in Framingham. J Chron Dis1967; 20: 511–524.
2.
KeysA.Coronary heart disease in seven countries.New York: American Heart Association; 1970.
3.
KornitzerMDramaixMGheyssensH.Incidence of ischaemic heart disease in two Belgian cohorts followed during 10 years. Eur J Cardiol1979; 9: 455–472.
4.
KornitzerMDramaixMBeriotILannoyMGheyssensHKittelF.Twenty-five-year mortality follow-up in the Belgian Bank Study. Cardiology1993; 82: 153–171.
5.
MillerGFMillerNE.Plasma-high-density lipoprotein concentration and development of ischaemic heart disease. Lancet1975; 1: 16–19.
6.
HjermannIByreK VelveHolmeILerenP.Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet1981; 11: 1303–1310.
7.
KornitzerMDe BackerGDramaixMKittelFThillyCGraffarM. Belgian Heart Disease Prevention Project: incidence and mortality results. Lancet1983; 1: 1066–1070.
8.
The Multiple Risk Factor Intervention Trial Research Group.Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation1996; 94: 946–951.
9.
EbrahimSSmithG. DaveySystematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ1997; 314: 1666–1674.
10.
AndersonKMWilsonPWFOdellPMKannelWB.An updated coronary risk profile. A statement for health professionals. Circulation1991; 83: 356–362.
11.
Tunstall-PedoeH.The Dundee coronary risk-disk management of change in risk factors. BMJ1991; 303: 744–747.
12.
ThorsenRDJacobsDRGrimmRHKeysATaylorHBlackburnH.Preventive cardiology in practice: a device for risk estimation and counseling in coronary disease. Prev Med1979; 8: 548–556.
13.
PyöräläKDe BackerGGrahamIPoole-WilsonPWoodD on behalf of the task force. Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J1994; 15: 1300–1331.
14.
World Health Organization European collaborative group.An international controlled trial in the multifactorial prevention of coronary heart disease. Int J Epidemiol1974; 3: 219–224.
15.
ThillyCKornitzerMRamioulLWilmetMDe BackerGRoseG.Prediction of coronary risk in middle-aged men. Arch Mal Cœur Vaiss1975; 68: 101–105.
16.
KornitzerMBaraLfor the BIRNH Study Group. Clinical and anthropometric data, blood chemistry and nutritional patterns in the Belgian population according to age and sex. Acta Cardiol1989; 44: 101–144.
17.
RoseGABlackburnHGillumRFPrineasRJ.Cardiovascular survey methods.Geneva: World Health Organization; 1982.
18.
SobolskiJKornitzerMDe BackerGDramaixMAbramoviczMDegreS. Protection against ischemic heart disease in the Belgian Physical Fitness Study: physical fitness rather than physical activity?Am J Epidemiol1987; 125: 601–610.
19.
Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA1993; 269: 3015–3023.
20.
CleemanJIRocellaEJLenfantCI.Reducing cardiovascular disease: the United States national education programs for high blood pressure and cholesterol control. Arch Pub Health1991; 49: 95–106.
21.
WoodDDe BackerGFaergemanOGrahamIManciaGPyöräläK.Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J1998; 19: 1434–1503.
22.
HaqIUJacksonPRYeoWWRamsayLE.Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet1995; 346: 1467–1471.
23.
KeysAAravanisCBlackburnHBuzniaRDjorjevicBDontasASSeven countries. A multivariate analysis of death and coronary heart disease.Cambridge, MA: Harvard University Press; 1980. pp. 286–290.
24.
HaqIURamsayLEYeoWWJacksonPRWallisEJ.Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart1999; 81: 40–46.
25.
ERICA Research Group.Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA project. Eur Heart J1991; 12: 291–297.
26.
Working group of the Coronary Prevention Group and the British Heart Foundation.An action plan for preventing coronary heart disease in primary care. BMJ1991; 303: 748–750.
